Ribose (Furanose)

Ribose (Furanose)

SCHEMBL2505730

Clc1ncnc2[nH]cnc12.OC[C@H]1O[C@@H](O)[C@H](O)[C@@H]1O

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 3/20 0.40
▸ SLC29A1 Q99808 2/20 0.40
▸ HSPA8 P11142 3/20 0.39
▸ HSPA5 P11021 2/20 0.39
▸ HIF1A Q16665 3/20 0.38
▸ STAT6 P42226 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ SLC28A2 O43868 2/20 0.38
▸ DPP4 P27487 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ SLC28A1 O00337 1/20 0.38
▸ MAP3K7 O43318 1/20 0.38
▸ GAPDH P04406 1/20 0.38
▸ ADORA3 P0DMS8 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ ADORA2A P29274 1/20 0.38
▸ ADORA2B P29275 1/20 0.38
▸ ADORA1 P30542 1/20 0.38
▸ PI4KA P42356 1/20 0.38
▸ KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ribose (Furanose) SCHEMBL4542668 1.00 ADK (0.40) ADKSLC29A1HSPA8HSPA5HIF1A
Adenine SCHEMBL14636444 0.85 HIF1A (0.49) ADKSLC29A1HSPA8HSPA5HIF1A
6-Chloroguanine SCHEMBL10674719 0.84 LMNA (0.40) SLC29A1HIF1ASTAT6SMN1; SMN2MEN1
Ribose (Furanose) SCHEMBL2497745 0.83 LMNA (0.49) HIF1ASTAT6SMN1; SMN2MEN1ADORA3
Adenine SCHEMBL9007542 0.80 FBP1 (0.46) ADKSLC29A1HSPA8HSPA5HIF1A
Ribose (Furanose) SCHEMBL8605925 0.79 ADK (0.40) ADKSLC29A1HIF1ASTAT6SMN1; SMN2
Ribose (Furanose) SCHEMBL17824409 0.79 ADK (0.40) ADKSLC29A1HIF1ASTAT6SMN1; SMN2
Ribose (Furanose) SCHEMBL4542672 0.79 ADK (0.40) ADKSLC29A1HIF1ASTAT6SMN1; SMN2
SCHEMBL7764674 0.77 ADK (0.54) ADKTSHR
SCHEMBL9081 0.76 CHEK1 (0.42) SMN1; SMN2DPP4MEN1ADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8501708-B2 Adenosine compounds and their use thereof INOTEK PHARMACEUTICALS CORPORATION (US) 2013-08-06 — — US disclosed
CN-102822188-A Adenosine compounds and their use thereof INOTEK PHARMACEUTICALS CORP 2012-12-12 — — CN disclosed
US-20110245194-A1 ADENOSINE COMPOUNDS AND THEIR USE THEREOF INOTEK PHARMACEUTICALS CORPORATION (US) 2011-10-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245194-A1 ADENOSINE COMPOUNDS AND THEIR USE THEREOF ADORA1, ADORA2A, ADORA3 ADK 18/4885SLC29A1 44/4885HSPA8 3332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback